Sort
15,273 grants matching “antimicrobial resistance”
Biochemistry of Energy-Dependent (Intracellular) Protein Degradation
$926,883Michael Maurizi · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
Identifying novel anti-infectives by high through-put screening in whole animals
$926,799Frederick M Ausubel · Massachusetts General Hospital · R01 · FY2010 · AI
Optimized Combination Antimalarial Drug Therapy
$923,203Paul D. Roepe · Georgetown University · R01 · FY2017 · AI
Optimized Combination Antimalarial Drug Therapy
$923,203Paul D. Roepe · Georgetown University · R01 · FY2016 · AI
Phenotype MicroArray Analysis of Fastidious Pathogens
$923,041Barry Ronald Bochner · Biolog, Inc. · R42 · FY2009 · GM
Mechanisms underlying bacterial sensitivity to host-targeted drugs
$922,904Amir Mitchell · Univ Of Massachusetts Med Sch Worcester · R01 · FY2025 · AI
Human Monoclonal Antibody To Treat P. aeruginosa Infections in Cystic Fibrosis
$922,387Eric John Patzer · Aridis Pharmaceuticals, Llc · R42 · FY2011 · AI
Boosting Innate Immunity Through HIF to Treat Antibiotic-Resistant Infections
$922,225Victor Nizet · University Of California, San Diego · R01 · FY2013 · AI
Integrated Comprehensive Droplet Digital Detection (IC 3D) system for rapid detection of bacteria andantimicrobial resistance
$921,581Weian Zhao · University Of California-Irvine · R01 · FY2019 · AI
Host defense-stimulating macrocyclic peptides for treatment of MDR bacterial infections
$920,556Michael E Selsted · University Of Southern California · R01 · FY2019 · AI
Genes/Pathways for ATG Gene-dependent Inhibition of Viruses & Parasite Infection
$920,338Herbert W Virgin · Washington University · U19 · FY2016 · AI
Sustained release gel enabling one-stage treatment of prosthetic joint infection
$919,432Derek James Overstreet · Sonoran Biosciences, Inc. · R44 · FY2017 · AR
Efficacy of Tympanostomy Tubes for Children with Recurrent Acute Otitis Media
$918,949Alejandro Hoberman · University Of Pittsburgh At Pittsburgh · U01 · FY2019 · DC
RNA: New Antimicrobial Strategies
$918,516Adrian Ferre-D'amare · National Heart, Lung, And Blood Institute · ZIA · FY2020 · HL
Pathogenic differences between Cryptococcus neoformans and C. gattii
$918,369Kyung Kwon-Chung · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
Improving Antimicrobial Prescribing Practices in the Neonatal Intensive Care Unit
$917,083Lisa Saiman · Columbia University Health Sciences · R01 · FY2012 · NR
Bacterial Drug Susceptibility Identification by Surface Enhanced Raman Microscopy
$915,942Alexis F Sauer-Budge · Fraunhofer Center /Manufacturing Innov · R01 · FY2010 · AI
Broad-spectrum Antifolates for Treatment of Drug Resistant Bacillus anthracis
$915,887William Barrow · Oklahoma State University Stillwater · R01 · FY2011 · AI
Targeting superbugs: discovery and development of new broad-spectrum lipopeptides
$915,110Jian Li · Monash University · R01 · FY2012 · AI
Task D02: Pre-Clinical Pharmacokinetic Services
$915,076Mary Bastida · Sri International · N01 · FY2019 · AI
Ultrarapid culture-independent detection of high-priority carbepenem resistant Enterobacteriaceae directly from blood
$914,966Connie Savor Price · Denver Health And Hospital Authority · R01 · FY2016 · AI
Determinants of S. aureus Colonization in Atopic Dermatitis
$914,886Kathleen C Barnes · National Jewish Health · U19 · FY2015 · AI
Ultrarapid culture-independent detection of high-priority carbepenem resistant Enterobacteriaceae directly from blood
$914,354Connie Savor Price · Denver Health And Hospital Authority · R01 · FY2017 · AI
Improving Antimicrobial Prescribing Practices in the Neonatal Intensive Care Unit
$911,785Lisa Saiman · Columbia University Health Sciences · R01 · FY2009 · NR
OPTIMIZE - CCC - Lead Application
$910,954Bonnie W Ramsey · Seattle Children'S Hospital · U01 · FY2017 · HL